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Herein is provided an alternate, simple, multigram scale, efficient route for Biginelli reaction for synthesis of 
dihydropyrimidinones using urea, ethylacetatoacetate, and benzaldehyde with pivalic acid. 
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Dihydropyrimidinones are well known for their wide 
range of biological responses. They exhibit antitumor, 
antibacterial, antiviral, anti-inflammatory activities, etc. 
(Figure 1). Several alkaloids containing dihydropyri 
midinone as core structural unit are isolated from marine 





First prepared by Biginelli reaction, a 
multicomponent one-pot reaction involving urea, 
ethylacetoacetate and benzaldehyde, Dihydropyri 
midinone and its derivatives are extensively studied 
with diverse catalyst, solvents, unconventional methods 
like microwave, ultrasound, solid supported reagents, 




Multicomponent reactions are preferred strategy for 
organic synthesis due to their convergent character, 
economic nature and energy and time saving factor. 
Dihydropyrimidinones prepared by exploring several 
acid catalysts such as mineral acids, acetic acid, lewis 
acids, metal halides, etc. Acid catalysed activation of 
electrophiles is a most probable mode of catalytic 
action
11-15
. However, a simple, fast, mild, low cost 




Results and Discussion 
We herein provide an alternate, simple and 
efficient route for synthesis of dihydropyrimidinones 
using urea, ethylacetoacetate and benzaldehyde with 
pivalic acid as catalyst as well as solvent. Pivalic acid 
is a water soluble, very low melting, mild and 
sterically hindered carboxylic proton donor
21-25
. 
The reaction when tried without any catalyst entails 
long reaction time and low yield. The amount of 
pivalic acid was then varied and optimised to give 
highest yield (Scheme I, Table I). Water miscibility of 
pivalic acid practically hindered its reusability. 
The methodology was further explored with various 
other substituted benzaldehydes and thiourea to get 
corresponding dihydropyrimidinones and dihydrothio 
pyrimidinones
26-34
. (Scheme II, Table II) 
 
 





Scheme I — Optimisation study for dihydropyrimidinones and 
dihydrothiopyrimidinones with urea and thiourea respectively 
along with benzaldehyde and ethylacetoacetate 




On successfully exploiting this methodology for 
several derivatives of Biginelli product, we herein 
propose a probable mechanism for the multicomponent 




Representative procedure for dihydropyrimidinone 1a 
In a 100 mL round bottom flask, benzaldehyde  
(1 mL, 1.06 g, 0.01 mol), urea (0.91 g, 0.015 mol), 
ethylacetoacetate (1.3 mL, 1.301 g, 0.01 mol) and 
pivalic acid (1 mL), were stirred at 125ºC for 2 h. After 
completion of the reaction, EtOH (5 mL) was added to 
this content and immediately poured into 500 mL 
beaker containing ice. The solid product was filtered, 
washed with EtOH:H2O (1:1) mixture and dried in air. 
Analytically pure product (92 %, 2.41 g) was obtained 
as white solid on recrystallisation with EtOAc. 
 
Representative procedure for dihydrothiopyrimidinone, 1l 
In a 100 mL round bottom flask, benzaldehyde  
(1 mL, 1.06 g, 0.01 mol), thiourea (1.151 g, 0.015 
mol), ethylacetoacetate (1.3 mL, 1.301 g, 0.01 mol) and 
pivalic acid (1 mL), were stirred at 135ºC for 3 h. After 
completion of the reaction, EtOH (5 mL) was added to 
this content and immediately poured into 500 mL beaker 
containing ice. The solid product was filtered, washed 
with EtOH:H2O (3:1) mixture and dried in air. 
Analytically pure product (73 %, 2.015 g) was obtained 





H NMR (400 MHz, 
DMSO-d6): δ 1.09 (t, J = 7.2 Hz, 3H), 2.24 (s, 3H), 
3.98 (q, J = 7.2 Hz, 2H), 5.14 (s, 1H), 7.24 (m, 3H), 




H NMR (400 MHz, DMSO-d6): δ 1.11 (t, J = 7.2 Hz, 
3H), 2.23 (s, 3H), 3.71 (s, 3H), 3.98 (q, J = 7.2 Hz, 
2H), 5.09 (s, 1H), 6.86 (d, J = 8.8 Hz, 2H), 7.15 (d, J 





(400 MHz, DMSO-d6): δ 1.10 (t, J = 7.2 Hz 3H), 2.24 
(s, 3H), 3.97 (q, J = 7.2 Hz, 2H), 5.14 (s, 1H), 7.24 






(400 MHz, DMSO-d6): δ 1.08 (t, J = 7.2 Hz, 3H), 
2.24 (s, 3H), 3.98 (q, J = 7.2 Hz, 2H), 5.14 (s, 1H), 





(400 MHz, DMSO-d6): δ 1.16 (t, J = 7.2 Hz, 3H), 
2.21 (s, 3H), 4.05 (q, J = 7.2 Hz, 2H), 5.40 (s, 1H), 
6.88 (m, 1H), 6.93 (m, 1H), 7.35 (m, 1H), 7.91 (s, 
1H), 9.32 (s, 1H). 
Ethyl 4-(3-methoxyphenyl)-6-methyl-2-oxo-1,2, 
3,4-tetrahydropyrimidine-5-carboxylate, 1f: 
1H NMR (400 MHz, DMSO-d6): δ 1.11 (t, J = 7.2 Hz, 
3H), 2.24 (s, 3H), 3.75 (s, 3H), 3.98 (q, J = 7.2 Hz, 
2H), 5.11 (s, 1H), 6.76 (s, 1H), 6.80 (m, 2H), 7.24 (t, 
J = 8.0 Hz, 1H), 7.73 (s, 1H), 9.19 (s, 1H). 
Ethyl 4-(3,4-dimethoxyphenyl)-6-methyl-2-oxo-
1,2,3,4-tetrahydropyrimidine-5-carboxylate, 1g:  
1
H NMR  (400 MHz,   DMSO-d6): δ 1.11 (t, J = 6.8 
 
Scheme II — Derivatives of dihydropyrimidinones and 
dihydrothiopyrimidinones 
 
Table I — Optimisation study for dihydropyrimidinones and dihydrothiopyrimidinones 
Entry Pivalic acid 
For Dihydropyrimidinones a For Dihydrothiopyrimidinones b 
Reaction conditions & Time Yield (%)  Reaction conditions & Time Yield (%) 
1 1 mL RT, 4 h 20 RT, 4 h <2 
2 1 mL 80 ºC, 2 h 55 125 ºC, 2 h 25 
3 1 mL 125 ºC, 2 h 92 135 ºC, 3 h 73 
4 2 mL 125 ºC, 2 h 91 135 ºC, 3 h 74 
5 - 125 ºC, 4 h 48 135 ºC, 4 h 5 
a Reaction condition for dihydropyrimidinone: Benzaldehyde (0.01 mol) Ethylacetoacetate (0.01 mol), Urea (0.015 mol). 
b Reaction condition for dihydrothiopyrimidinone: Benzaldehyde (0.01 mol) Ethylacetoacetate (0.01 mol), Thiourea (0.015 mol). 
 





Table II — Synthesis of dihydropyrimidinones and dihydrothiopyrimidinonesa 














































































































a Reaction condition for dihydropyrimidinone: Benzaldehyde (0.01 mol) Ethylacetoacetate (0.01 mol), Urea (0.015 mol), Pivalic acid 
(1 mL), 125 ºC, 2 h. 
Reaction condition for dihydrothiopyrimidinone: Benzaldehyde (0.01 mol) Ethylacetoacetate (0.01 mol), Thiourea (0.015 mol), Pivalic 
acid (1 mL), 135 ºC, 3 h. b Isolated yield. 




Hz, 3H), 2.24 (s, 3H), 3.71 (s, 6H), 4.00 (q, J = 6.8 
Hz, 2H), 5.09 (s, 1H), 6.71 (s, 1H), 6.87 (m, 2H), 7.68 





H NMR (400 MHz, DMSO-d6): δ 1.13 (t, J = 6.8 Hz, 
3H), 2.25 (s, 3H), 3.62 (s, 3H), 3.71 (s, 6H), 4.01 (q, J 
= 6.4 Hz, 2H), 5.11 (s, 1H), 6.52 (s, 2H), 7.73 (s,1H), 






(400 MHz, DMSO-d6): δ 1.09 (t, J = 7.2 Hz, 3H), 
2.24 (s, 3H), 3.97 (q, J = 7.2 Hz, 2H), 5.14 (s, 1H), 
7.25 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 
7.78 (s, 1H), 9.26 (s, 1H). 
 
Ethyl 6-methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahy 
dropyrimidine-5-carboxylate, 1j: 1H NMR (400 MHz, 
DMSO-d6): δ 1.08 (t, J = 7.2 Hz, 3H), 2.29 (s, 3H), 
4.00 (q, J = 7.2 Hz, 2H), 5.17 (s, 1H), 7.22 (m, 2H), 




1H NMR (400 MHz, DMSO-d6): δ 1.10 (t, J = 7.2 Hz, 
3H), 2.28 (s, 3H), 3.72 (s, 3H), 3.99 (q, J = 7.2 Hz, 
2H), 5.10 (s, 1H), 6.88 (d, J = 8.8 Hz, 2H), 7.11 (d, J 





H NMR (400 MHz, DMSO-d6): δ 0.93 (t, J = 7.2 Hz, 
3H), 2.31 (s, 3H), 3.86 (q, J = 7.2 Hz, 2H), 5.95 (s, 
1H), 7.53 (m, 2H), 7.76 (m, 2H), 7.93 (m, 1H), 9.63 





H NMR (400 MHz, DMSO-d6): δ 1.08 (t, J = 7.2 Hz, 
3H), 2.28 (s, 3H), 3.98 (q, J = 7.2 Hz, 2H), 5.16 (s, 




1H NMR (400 MHz, DMSO-d6): δ 1.16 (t, J = 7.2 Hz, 
3H), 2.26 (s, 3H), 4.06 (q, J = 7.2 Hz, 2H), 5.42 (s, 
1H), 6.89 (m, 1H), 6.97 (m, 1H), 7.40 (m, 1H), 9.79 





H NMR (400 MHz, DMSO-d6): δ 1.12 (t, J = 7.2 Hz, 
3H), 2.28 (s, 3H), 3.72 (s, 3H), 4.01 (q, J = 7.2 Hz, 
 
 
Figure 2 — Probable mechanism for pivalic acid assisted formation of dihydropyrimidinones 
 





2H), 5.14 (s, 1H), 6.77 (m, 2H), 6.86 (m, 1H), 7.27 





H NMR (400 MHz, DMSO-d6): δ 1.12 (t, J = 7.2 Hz, 
3H), 2.28 (s, 3H), 3.71 (s, 6H), 3.99 (q, J = 7.2 Hz, 
2H), 5.11 (s, 1H), 6.69 (m, 1H), 6.82 (s, 1H), 6.90 (s, 





H NMR (400 MHz, DMSO-d6): δ. 1.14 (t, J = 6.8 Hz, 
3H), 2.28 (s, 3H), 3.62 (s, 3H ), 3.72 (s, 6H), 4.03 (q, J = 
6.4 Hz, 2H), 5.14 (s, 1H), 6.50 (s, 2H), 9.63 (s, 1H), 





H NMR (400 MHz, DMSO-d6): δ 1.10 (t, J = 7.2 Hz, 
3H), 2.26 (s, 3H), 2.28 (s, 3H), 4.01 (q, J = 7.2 Hz, 2H), 
5.12 (s, 1H), 7.08 (d, J = 8.0 Hz, 2H), 7.15 (d, J = 8.0 
Hz, 2H), 9.62 (s, 1H), 10.31 (s, 1H). 
 
Conclusion 
The pivalic acid has been used for the first time for an 
alternate, mild, one-pot, multicomponent, multigram 
scale, efficient method for Biginelli reaction for the 
synthesis of dihydropyrimidinones. 
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